<DOC>
	<DOC>NCT02837783</DOC>
	<brief_summary>The objective of this trial is to determine the effect of linaclotide on abdominal girth in irritable bowel syndrome with constipation (IBS-C) participants with the baseline symptoms of abdominal bloating and an increased abdominal girth.</brief_summary>
	<brief_title>A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>â€¢ Patient meets protocol criteria for diagnosis of IBSC, abdominal pain, abdominal bloating and abdominal girth Patient has history of loose or watery stools Patient has both clinically significant findings and unexplained clinically significant alarm symptoms Patient has symptoms of or been diagnosed with a medical condition that may contribute to abdominal pain Patient has any protocolexcluded or clinically significant medical or surgical history that could confound the study assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>